Is there concordance between LV fibrosis and RV fibrosis in patients with hypertrophic cardiomyopathy; should there be?

被引：0
|
作者：
Nessim N Amin
Saundra Grant
June A Yamrozik
Ronald B Williams
Diane V Thompson
Moneal Shah
Mark Doyle
Robert W Biederman
机构：
[1] Allegheny General Hospital,Cardiac MRI
来源：
Journal of Cardiovascular Magnetic Resonance | / 16卷 / Suppl 1期
关键词：
Ejection Fraction; Cardiomyopathy; Genetic Abnormality; Predictive Power; Retrospective Review;
D O I：
10.1186/1532-429X-16-S1-P313
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
    Ho, Carolyn Y.
    Lopez, Begona
    Coelho-Filho, Otavio R.
    Lakdawala, Neal K.
    Cirino, Allison L.
    Jarolim, Petr
    Kwong, Raymond
    Gonzalez, Arantxa
    Colan, Steven D.
    Seidman, J. G.
    Diez, Javier
    Seidman, Christine E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06): : 552 - 563
  • [42] SANDOSTATIN DECREASES MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY
    TARABEN, A
    CAMPBELL, SE
    JONES, J
    KOPPLIN, D
    KHARDORI, R
    CIRCULATION, 1995, 92 (08) : 2521 - 2521
  • [43] FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY - ITS POSSIBLE PATHOGENESIS
    BERANEK, JT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) : 519 - 519
  • [44] Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy and High Risk for Sudden Death
    Shiozaki, Afonso Akio
    Senra, Tiago
    Arteaga, Edmundo
    Pita, Cristiane Guedes
    Martinelli Filho, Martino
    Avila, Luis Francisco R.
    Parga Filho, Jose Rodrigues
    Mady, Charles
    Rochitte, Carlos Eduardo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (04) : 535 - 540
  • [45] Detection of myocardial fibrosis in patients with hypertrophic cardiomyopathy evaluated by biological markers
    Amira, Zaroui
    Tej, El Chalbia
    Rim, Ben Said
    Manel, Ben Hallima
    Nadim, Khedher
    Abdelj, Farhati
    Sami, Mourali
    Rachid, Mechmeche
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 306 - 307
  • [46] Type of fibrosis predicts serious events in patients with obstructive hypertrophic cardiomyopathy
    Almaas, V. M.
    Strom, E. Heyerdahl
    Scott, H.
    Dahl, C. P.
    Edvardsen, T.
    Aakhus, S.
    Geiran, O. R.
    Amlie, J. P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 35 - 35
  • [47] Myocardial work: a new way to predict fibrosis in patients with hypertrophic cardiomyopathy
    Valentim Goncalves, A.
    Aguiar Rosa, S.
    Moura Branco, L.
    Galrinho, A.
    Fiarresga, A.
    Lopes, L. Rocha
    Thomas, B.
    Baquero, L.
    Mota Carmo, M.
    Cruz Ferreira, R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 89 - 89
  • [48] Detection of myocardial fibrosis in patients with hypertrophic cardiomyopathy evaluated by biological markers
    Zaroui, A.
    Asmi, M.
    Tejelbenet, C.
    Ben Said, R.
    Kaabachi, N.
    Mourali, M. S.
    Mechmeche, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 146 - 146
  • [49] Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
    Guo, Xinli
    Zhang, Jian
    Huang, Manyun
    Song, Changpeng
    Nie, Changrong
    Zheng, Xinxin
    Wang, Shuiyun
    Huang, Xiaohong
    ESC HEART FAILURE, 2025, 12 (01): : 582 - 591
  • [50] Effects of candesartan on left ventricular hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy
    Maqsood, H.
    Shakeel, H. A.
    Shoukat, H. F.
    Khan, M. D.
    Shah, S. A. Y.
    Gulraiz, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3360 - 3360
12345